HF
MENS

HRT Financial’s Jyong Biotech MENS Stock Holding History

HRT Financial’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Buy
+11,767
New +$28.8K ﹤0.01% 3547
2025
Q4 		– Sell
-20,819
Closed -$819K – 4330
2025
Q3 		$819K Sell
20,819
-2,103
-9% -$75.7K ﹤0.01% 1627
2025
Q2 		$190K Buy
+22,922
New +$197K ﹤0.01% 2091

Other funds holding MENS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's MENS Position: Q1 2026 in Review

HRT Financial opened a new position in Jyong Biotech (MENS) in Q1 2026: 11,767 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #3547 among its holdings. This is a return to the name: HRT Financial previously reported a position in MENS as recently as Q3 2025.

HRT Financial first reported a position in MENS in Q2 2025 and has held it in 3 quarters since. The position peaked at $819K in Q3 2025. 17 funds tracked by Wall St. Rank hold MENS as of Q1 2026.

  • HRT Financial held 11,767 shares of Jyong Biotech worth $25K as of Q1 2026.
  • Jyong Biotech was a new HRT Financial position in Q1 2026.
  • Jyong Biotech made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3547 holding.
  • HRT Financial first reported a position in Jyong Biotech in Q2 2025 and has held it in 3 quarters since.
  • HRT Financial's Jyong Biotech position peaked at $819K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Jyong Biotech as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.